Protective efficacy of Toxoplasma gondii bivalent MAG1 and SAG1 DNA vaccine against acute toxoplasmosis in BALB/c mice
Parasitology Research · 2023
DOI: 10.1007/s00436-022-07745-8 ↗Kurz gefasst
Fachartikel in der Zeitschrift Parasitology Research, 2023. Verfasst von Lili Cao und 12 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Zoonotic Diseases, College of Veterinary Medicine, Jilin University, Changchun, 130062, China. Hauptthemen laut MEDLINE: Toxoplasma, Vaccines, DNA, Toxoplasmosis, Protozoan Vaccines. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 36 Literaturangaben. Gefördert von: the scientific and technological planning project of Jilin province, Jilin Scientific and Technological Development Program, National Key R&D Program of China.
Abstract (Originalsprache)
Toxoplasma gondii can infect a wide range of warm-blooded animals, causing a global toxoplasmosis zoonotic epidemic. Surface antigen 1 (SAG1) protein is expressed at the proliferative tachyzoite stage, whereas matrix antigen 1 (MAG1) is expressed at the bradyzoite and tachyzoite stages. These two proteins were found to perform protective roles in previous studies; however, their synergetic protective efficacy as a DNA vaccine against toxoplasmosis has not been clarified. In this study, we constructed recombinant pcDNA3.1( +)-TgMAG1 (pMAG1), pcDNA3.1( +)-TgSAG1 (pSAG1), and pcDNA3.1( +)-TgMAG1-TgSAG1 (pMAG1-SAG1) plasmids and administered them intramuscularly to immunize mice. The levels of anti-T. gondii IgG in serum and cytokines, such as Interleukin (IL)-4, IL-10, and Interferon (IFN)-γ, in splenocytes were measured using ELISA and the respective culture supernatants. Lethal doses of T. gondii (type I) RH strain tachyzoites were administered to immunized mice, and mortality was assessed. Conversely, mice infected with low doses of tachyzoites were monitored to determine their survival rates, and parasite burden analyses of the brains and livers were conducted. The bivalent TgMAG1 and TgSAG1 DNA vaccines exhibited excellent protective immunity against toxoplasmosis in mice, with higher serum IgG and splenocyte IFN-γ release levels, longer survival days, and reduced parasite burden in the brain and liver tissues (p < 0.05). These findings provide a new perspective for the development of T. gondii vaccines.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Zoonotic Diseases, College of Veterinary Medicine, Jilin University, Changchun, 130062, China.
- Jilin Academy of Animal Husbandry and Veterinary Medicine, Changchun, 130062, China.
- Pingdu People's Hospital, Qingdao, 266700, China.
- State Key Laboratory of Rice Biology, Lianyungang Academy of Agricultural Sciences, Lianyungang, 222000, China.
- Metabolism of Infection Groups, Max Planck Institute for Biology of Aging, Cologne, Germany. lxianhe@age.mpg.de.
- State Key Laboratory of Zoonotic Diseases, College of Veterinary Medicine, Jilin University, Changchun, 130062, China. gongpt@jlu.edu.cn.
Förderung
- the scientific and technological planning project of Jilin province
- Jilin Scientific and Technological Development Program
- National Key R&D Program of China
Zitieren
APA
Cao, L., Liu, J., Cao, S., Zhao, P., Sun, X., Dong, H., Bello, B. K., Guo, Y., Wang, N., Zhang, N., Li, Y., Li, X., & Gong, P. (2023). Protective efficacy of Toxoplasma gondii bivalent MAG1 and SAG1 DNA vaccine against acute toxoplasmosis in BALB/c mice. Parasitology Research. https://doi.org/10.1007/s00436-022-07745-8
Vancouver
Cao L, Liu J, Cao S, Zhao P, Sun X, Dong H, et al. Protective efficacy of Toxoplasma gondii bivalent MAG1 and SAG1 DNA vaccine against acute toxoplasmosis in BALB/c mice. Parasitology Research. 2023. doi:10.1007/s00436-022-07745-8
BibTeX
@article{Cao2023,
author = {Cao, Lili and Liu, Juan and Cao, Songgao and Zhao, Panpan and Sun, Xingzhong and Dong, Hang and Bello, Babatunde Kazeem and Guo, Yanbing and Wang, Nan and Zhang, Nan and Li, Ying and Li, Xianhe and Gong, Pengtao},
title = {Protective efficacy of Toxoplasma gondii bivalent MAG1 and SAG1 DNA vaccine against acute toxoplasmosis in BALB/c mice},
journal = {Parasitology Research},
year = {2023},
doi = {10.1007/s00436-022-07745-8}
}
EUVIMED